No Data
US Stock MarketDetailed Quotes
TMO Thermo Fisher Scientific
Watchlist
488.300
-7.040-1.42% Trading 12/05 11:14 ET
493.630High488.234Low248.42KVolume
492.970Open495.340Pre Close121.80MTurnover0.06%Turnover Ratio32.00P/E (TTM)188.67BMarket Cap608.62452wk High27.70P/E (Static)386.37MShares415.60052wk Low4.16P/B188.33BFloat Cap669.496Historical High1.35Dividend TTM385.68MShs Float11.917Historical Low0.28%Div YieldTTM1.09%Amplitude490.304Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Thermo Fisher Scientific Company
Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment is composed of a portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of infection and disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment provides diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment is involved in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.
Revenue Breakdown
Business
Currency:USD
2022/12/31
Stock NameRevenueRatio
Laboratory Products and Biopharma Services22.51B50.12%
Life Sciences Solutions13.53B30.13%
Analytical Instruments6.62B14.75%
Specialty Diagnostics4.76B10.60%
Eliminations-2.52B-5.60%
News
Goldman Sachs: Top 30 Mutual Fund Underweight Holdings, Including Apple and Tesla
Thermo Fisher Scientific and Project HOPE Partner to Advance Health Equity Among HIV Positive Youth in Sub-Saharan Africa
Collaboration designed to improve health outcomes by enabling expanded access to HIV testing and support services in Nigeria Thermo Fisher Scientific Inc., the world leader in serving science, and Project HOPE, a
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink
Offer Now Scheduled to Expire at 5:00 p.m., New York Time, on December 14, 2023WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher"), the world leader in serving
Comments
ColumnsToday's Morning Movers and Top Ratings: MSFT, GOOGL, BA, CME and More
Morning Movers
Gapping up
$Microsoft(MSFT.US$ stock rose 3.7% after the software giant reported better than expected fiscal first-quarter results, driven by stronger growth in its cloud business Azure. Azure's revenues jumped 29% during the period.
$Boeing(BA.US$ stock rose 3.7% after the aircraft manufacturer stuck to its goal of generating $3 billion to $5 billion in free cash flow this year despite cutting its 737 delivery...
Gapping up
$Microsoft(MSFT.US$ stock rose 3.7% after the software giant reported better than expected fiscal first-quarter results, driven by stronger growth in its cloud business Azure. Azure's revenues jumped 29% during the period.
$Boeing(BA.US$ stock rose 3.7% after the aircraft manufacturer stuck to its goal of generating $3 billion to $5 billion in free cash flow this year despite cutting its 737 delivery...
17
1
ColumnsNovo Nordisk Sets New Record High: Analyzing the Market Effects of Popular GLP-1 Weight Loss Drugs
The increasing demand for GLP-1 weight-loss medications indicates that in the next ten years, a significant number of Americans may lose hundreds of millions of pounds collectively. This shift in weight could cause a redistribution of trillions of dollars.
Last week, $Novo-Nordisk A/S(NVO.US$ presented evidence of a speeding trend when it announced that the primary component of Ozempic and Wegovy, ...
Last week, $Novo-Nordisk A/S(NVO.US$ presented evidence of a speeding trend when it announced that the primary component of Ozempic and Wegovy, ...
17
Read more
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Mon-Dellia Smith : crazy